Ensitrelvir Reveals a Bonus Capability

posted in: Uncategorized | 0

Main audience: everyone

We knew ensitrelvir (sold as Xocova in Japan, also available in Singapore) is effective against acute COVID, with fewer gotchas than Paxlovid. Guess what? It can also block transmission to a patient’s household 2/3 of the time if given to them soon enough.

Click here to read more.

Leave a Reply

Your email address will not be published. Required fields are marked *